Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00131014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    5 amendments

    5 re-verifications since 2023-08-28, no change to tracked fields

    v28-v32

  2. Notable

    Primary and study completion dates: Jan 2023 to Jan 2033

    Study Status, Contacts/Locationsv27

  3. Minor

    Start date: Aug 2004 to Aug 9, 2004

    Study Statusv26

  4. Minor

    2 amendments

    2 re-verifications since 2020-07-01, no change to tracked fields

    v24-v25

  5. Notable

    Trial status: Active, Not Recruiting to Recruiting

    Primary and study completion dates: Jan 2020 to Jan 2023; Site details revised

    Study Status, Contacts/Locationsv23

Show 21 earlier versions

  1. Minor

    Trial status: Recruiting to Active, Not Recruiting

    Site details revised

    Study Status, Contacts/Locationsv22

  2. Minor

    6 amendments

    6 re-verifications since 2014-04-22, no change to tracked fields

    v16-v21

  3. Minor

    Study Status, Outcome Measures, Contacts/Locations

    v15

  4. Minor

    3 amendments

    3 re-verifications since 2010-11-11, no change to tracked fields

    v12-v14

  5. Minor

    Site contact updated

    Study Status, Contacts/Locationsv11

  6. Minor

    2 amendments

    2 re-verifications since 2009-03-12, no change to tracked fields

    v9-v10

  7. Notable

    Enrollment target: 600 to 1500

    Primary and study completion dates: Aug 2009 to Jan 2020

    Study Status, Study Designv8

  8. Minor

    Site contact updated

    Study Status, Contacts/Locationsv7

  9. Minor

    Primary and study completion dates: Aug 2009

    Study Status, Sponsor/Collaborators, Study Design, Arms and Interventions, Eligibilityv6

  10. Minor

    Study Status

    Re-verified, no change to tracked fields

    v5

  11. Minor

    Enrollment target: 475 to 600

    Study Status, Study Designv4

  12. Minor

    Study Status

    Re-verified, no change to tracked fields

    v3

  13. Minor

    Eligibility criteria shortened, about 4 words

    Show what changed: Eligibility criteria
    Inclusion Criteria: Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder. Families; or families in which the individual has a lymphoproliferative disorder, [...] ering of frequent or premature solid tumors is also observed, will also be eligible. Family members of the individual, either affected or unaff [...] records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next o [...] ed tissue sampl [...]

    Study Identification, Study Status, Study Description, Conditions, Eligibilityv2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.
Trial Details
NCT Number NCT00131014
Lead Sponsor Dana-Farber Cancer Institute
Conditions Non-Hodgkin's Lymphoma, Hodgkin's Disease, Leukemia, Lymphocytic, Chronic, Lymphoproliferative Disorders
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov